Actelion appoints CFO
This article was originally published in Scrip
Executive Summary
Actelion, a biopharmaceutical firm developing treatments for pulmonary arterial hypertension, has appointed Andre C Muller chief financial officer – effective 1 September 2013. Prior to joining the Basel, Switzerland-based company Mr Muller was CFO at international pharmaceutical and cosmetic group, Pierre Fabre.